2024-04-012025-03-312025-03-31false05998832ERA Healthcare Limited2025-08-20falseiso4217:GBPxbrli:pure059988322024-03-31059988322025-03-31059988322024-04-012025-03-31059988322023-03-31059988322024-03-31059988322023-04-012024-03-3105998832bus:SmallEntities2024-04-012025-03-3105998832bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3105998832bus:AbridgedAccounts2024-04-012025-03-3105998832bus:PrivateLimitedCompanyLtd2024-04-012025-03-3105998832core:WithinOneYear2025-03-3105998832core:AfterOneYear2025-03-3105998832core:WithinOneYear2024-03-3105998832core:AfterOneYear2024-03-3105998832core:ShareCapital2025-03-3105998832core:SharePremium2025-03-3105998832core:RevaluationReserve2025-03-3105998832core:OtherReservesSubtotal2025-03-3105998832core:RetainedEarningsAccumulatedLosses2025-03-3105998832core:ShareCapital2024-03-3105998832core:SharePremium2024-03-3105998832core:RevaluationReserve2024-03-3105998832core:OtherReservesSubtotal2024-03-3105998832core:RetainedEarningsAccumulatedLosses2024-03-3105998832core:LandBuildings2025-03-3105998832core:PlantMachinery2025-03-3105998832core:Vehicles2025-03-3105998832core:FurnitureFittings2025-03-3105998832core:OfficeEquipment2025-03-3105998832core:NetGoodwill2025-03-3105998832core:IntangibleAssetsOtherThanGoodwill2025-03-3105998832core:ListedExchangeTraded2025-03-3105998832core:UnlistedNon-exchangeTraded2025-03-3105998832core:LandBuildings2024-03-3105998832core:PlantMachinery2024-03-3105998832core:Vehicles2024-03-3105998832core:FurnitureFittings2024-03-3105998832core:OfficeEquipment2024-03-3105998832core:NetGoodwill2024-03-3105998832core:IntangibleAssetsOtherThanGoodwill2024-03-3105998832core:ListedExchangeTraded2024-03-3105998832core:UnlistedNon-exchangeTraded2024-03-3105998832core:LandBuildings2024-04-012025-03-3105998832core:PlantMachinery2024-04-012025-03-3105998832core:Vehicles2024-04-012025-03-3105998832core:FurnitureFittings2024-04-012025-03-3105998832core:OfficeEquipment2024-04-012025-03-3105998832core:NetGoodwill2024-04-012025-03-3105998832core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105998832core:ListedExchangeTraded2024-04-012025-03-3105998832core:UnlistedNon-exchangeTraded2024-04-012025-03-3105998832core:MoreThanFiveYears2024-04-012025-03-3105998832core:Non-currentFinancialInstruments2025-03-3105998832core:Non-currentFinancialInstruments2024-03-3105998832dpl:CostSales2024-04-012025-03-3105998832dpl:DistributionCosts2024-04-012025-03-3105998832core:LandBuildings2024-04-012025-03-3105998832core:PlantMachinery2024-04-012025-03-3105998832core:Vehicles2024-04-012025-03-3105998832core:FurnitureFittings2024-04-012025-03-3105998832core:OfficeEquipment2024-04-012025-03-3105998832dpl:AdministrativeExpenses2024-04-012025-03-3105998832core:NetGoodwill2024-04-012025-03-3105998832core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105998832dpl:GroupUndertakings2024-04-012025-03-3105998832dpl:ParticipatingInterests2024-04-012025-03-3105998832dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3105998832core:ListedExchangeTraded2024-04-012025-03-3105998832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3105998832core:UnlistedNon-exchangeTraded2024-04-012025-03-3105998832dpl:CostSales2023-04-012024-03-3105998832dpl:DistributionCosts2023-04-012024-03-3105998832core:LandBuildings2023-04-012024-03-3105998832core:PlantMachinery2023-04-012024-03-3105998832core:Vehicles2023-04-012024-03-3105998832core:FurnitureFittings2023-04-012024-03-3105998832core:OfficeEquipment2023-04-012024-03-3105998832dpl:AdministrativeExpenses2023-04-012024-03-3105998832core:NetGoodwill2023-04-012024-03-3105998832core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3105998832dpl:GroupUndertakings2023-04-012024-03-3105998832dpl:ParticipatingInterests2023-04-012024-03-3105998832dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3105998832core:ListedExchangeTraded2023-04-012024-03-3105998832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3105998832core:UnlistedNon-exchangeTraded2023-04-012024-03-3105998832core:NetGoodwill2025-03-3105998832core:IntangibleAssetsOtherThanGoodwill2025-03-3105998832core:LandBuildings2025-03-3105998832core:PlantMachinery2025-03-3105998832core:Vehicles2025-03-3105998832core:FurnitureFittings2025-03-3105998832core:OfficeEquipment2025-03-3105998832core:AfterOneYear2025-03-3105998832core:WithinOneYear2025-03-3105998832core:ListedExchangeTraded2025-03-3105998832core:UnlistedNon-exchangeTraded2025-03-3105998832core:ShareCapital2025-03-3105998832core:SharePremium2025-03-3105998832core:RevaluationReserve2025-03-3105998832core:OtherReservesSubtotal2025-03-3105998832core:RetainedEarningsAccumulatedLosses2025-03-3105998832core:NetGoodwill2024-03-3105998832core:IntangibleAssetsOtherThanGoodwill2024-03-3105998832core:LandBuildings2024-03-3105998832core:PlantMachinery2024-03-3105998832core:Vehicles2024-03-3105998832core:FurnitureFittings2024-03-3105998832core:OfficeEquipment2024-03-3105998832core:AfterOneYear2024-03-3105998832core:WithinOneYear2024-03-3105998832core:ListedExchangeTraded2024-03-3105998832core:UnlistedNon-exchangeTraded2024-03-3105998832core:ShareCapital2024-03-3105998832core:SharePremium2024-03-3105998832core:RevaluationReserve2024-03-3105998832core:OtherReservesSubtotal2024-03-3105998832core:RetainedEarningsAccumulatedLosses2024-03-3105998832core:NetGoodwill2023-03-3105998832core:IntangibleAssetsOtherThanGoodwill2023-03-3105998832core:LandBuildings2023-03-3105998832core:PlantMachinery2023-03-3105998832core:Vehicles2023-03-3105998832core:FurnitureFittings2023-03-3105998832core:OfficeEquipment2023-03-3105998832core:AfterOneYear2023-03-3105998832core:WithinOneYear2023-03-3105998832core:ListedExchangeTraded2023-03-3105998832core:UnlistedNon-exchangeTraded2023-03-3105998832core:ShareCapital2023-03-3105998832core:SharePremium2023-03-3105998832core:RevaluationReserve2023-03-3105998832core:OtherReservesSubtotal2023-03-3105998832core:RetainedEarningsAccumulatedLosses2023-03-3105998832core:AfterOneYear2024-04-012025-03-3105998832core:WithinOneYear2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105998832core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3105998832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3105998832core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3105998832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3105998832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3105998832bus:Director12024-04-012025-03-3105998832bus:Director22024-04-012025-03-31

ERA Healthcare Limited

Registered Number
05998832
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

ERA Healthcare Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Deborah Riddy
Deborah Smyth

Company Secretary

Deborah Ann Smyth

Registered Address

136 High Street
Selsey
West Sussex
PO20 0QE

Registered Number

05998832 (England and Wales)
ERA Healthcare Limited
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors224216
Cash at bank and on hand65,59193,272
65,81593,488
Creditors amounts falling due within one year(73,820)(100,820)
Net current assets (liabilities)(8,005)(7,332)
Total assets less current liabilities(8,005)(7,332)
Net assets(8,005)(7,332)
Capital and reserves
Called up share capital100100
Profit and loss account(8,105)(7,432)
Shareholders' funds(8,005)(7,332)
The financial statements were approved and authorised for issue by the Board of Directors on 20 August 2025, and are signed on its behalf by:
Deborah Riddy
Director
Deborah Smyth
Director

Registered Company No. 05998832
ERA Healthcare Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2.Average number of employees

20252024
Average number of employees during the year00